Use of Two-Dimensional Liquid Chromatography Combined with Diode-Array and Mass Spectrometric Detection for Analysis of Compounds in Flos Lonicera

Comprehensive two-dimensional liquid chromatographic separation by means of a combination of ion-exchange chromatography (IEC) and reversed-phase liquid chromatography (RPLC) has been realized and applied to the analysis of components of a traditional Chinese medicine Flos Lonicera. In the first dimension the components of a Flos Lonicera extract is separated on strong anion-exchange (SAX) column according to the charge-exchange properties of the components. In the second dimension the components are further fractionated by reversed-phase liquid chromatography (on ODS) on the basis of their hydrophobicity. The RPLC effluent is desalted and split and the components are identified on-line by use of both diode-array detection and mass spectrometry with atmospheric pressure chemical ionization (APCI–MS). In this way, the extract of Flos Lonicera can be rapidly separated, desalted, and analyzed, with determination of molecular weight. More than 58 components of an extract of Flos Lonicera were well resolved and six were tentatively identified from their UV and mass spectra.     

微乳液增敏光度法测定中草药中微量硒

研究了在非离子微乳液介质中,硫氰酸盐罗丹明B 明胶体系分光光度法测定微量硒的方法。实验表明,当微乳液组成为V(OP乳化剂) +V(正戊醇) +V(正庚烷) +V(水) =1 5 0 +0 1 1+0 41 +97 98时,体系的表观摩尔吸收系数达1 3 0 1×1 0 6 L·mol- 1·cm- 1,灵敏度比在OP溶液中有显著提高,使该法成为少有的超高灵敏度测定硒的光度法之一。Se (Ⅳ)含量在0～0 0 5 μg·mL- 1范围内符合比耳定律,对0 0 2 μg·mL- 1Se(Ⅳ)平行测定1 1次,测得相对标准偏差为0 945 %。应用于中草药中微量硒的测定结果令人满意     

Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.     

微量元素与中医辩证分型

通过对两间小学639名学生进行微量元素检测及体格检查，并进行中医辩证分型，发现广州市部份小学生体内微量元素缺乏较严重，占体检总人数的62．3％，同时也存在营养不良，贫血、佝偻病，急慢性上呼吸道炎等、按中医辩证分型有肝热、脾气虚弱、肝血不足、肾气虚等，本文试从微量元素缺乏与中医辩证中找出两者之间的联系，以便于指导治疗，提高小学生的健康水平，增强体质和智力。     

内蒙古牧区蒙、汉族人发铜、锌、铁、锶及钙的X-射线荧光光谱法测定

用X-射线荧光光谱法，测定了387例内蒙古牧区蒙古族、汉族成人和儿童的发中铜(Cu)、锌(Zn)、铁(Fe)、锶(St)及钙(Ca)的含量，对同一地区蒙、汉族成人间，成人及儿童间发中五种元素含量进行了比较分析。结果表明：蒙汉族成人发中Cu，Zn、Fe含量不受种族及饮食习惯的影响，其含量无显著性差异；蒙汉族成人发中Sr和Ca含量存在着相平行的显著差异；牧区儿童发Zn含量与牧区成人发Zn含量差异无显著性意义，提示牧区儿童不缺Zn，可能与多动物性食物有关；牧区儿童发中Cu、Fe、Sr、Ca均显著低于牧区成人、可能与儿童发育旺盛和Zn摄入量高对Cu、Fe吸收发生抑制有关。     

中药配方颗粒红外光谱法的快速鉴别

采用红外光谱法对中药配方颗粒及其辅料进行了鉴别研究。结果表明：不同生产厂商的配方颗粒中所添加的辅料类型及用量有较大差别；不同种的配方颗粒在辅料含量较低的情况下有较明显的指纹性，而辅料含量较高时，采用差谱技术可以提高谱图的指纹性，达到中药配方颗粒--鉴别的目的。该法简便、快速、可靠，是中药配方颗粒宏观质控的一个强有力的手段。     

药物对微量元素锌吸收的影响

综合分析近年来有关的中外文献资料，讨论了临床常用药物对肠道锌吸收的影响及其意义。有十几类药物会对锌吸收产生影响。药物对锌吸收的影响在营养学及其临床上有重要意义，其中对锌吸收的抑制可能是锌缺乏的原因之一。     

壳聚糖对鞣酸絮凝作用的研究

以壳聚糖为絮凝剂，采用絮凝法除去中药药液中的杂质。以鞣酸为研究对象，从鞣酸浓度，体系温度，ＰＨ絮凝剂用量粘均分子量等方面探讨其絮凝规律，用正交试验优化其絮凝条件，为实施中药药液的絮凝法精制工艺提供参考。     

新的脉冲进样AAS法测定“麻杏石甘汤”中的微量金属元素

本文研制了一种新的脉冲进样装置，用于火娄原子吸收分光光度法测定中药煎剂中的Ｃａ，Ｍｇ，Ｆｅ，Ｍｎ，Ｚｎ五种金属元素含量，实验表明，利用此种装置可以同时获得两种进样方式的分析结果，线性范围比常规法宽两倍，耗样量，精密度及分析速度均优于常规法。     

从奎宁到白三烯——-试论有机化学在医学科学中的重要作用

有机化学,特别是天然有机化学,是和医学科学密切相关的,有机化学的成就在许多方面促进了医学科学的进步,反过来医学科学中提出的课题也推动了有机化学的发展。本文以抗疟药等天然药物和廿碳酸类等生理活性物质为例讨论了这两门学科间的一些关系。